Brief: Myriad Genetics Announces Research Collaboration For Minimal Residual Disease Testing Platform
12/06/2023 13:10
June 12 (Reuters) - Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS ANNOUNCES RESEARCH COLLABORATION TO USE
MINIMAL
RESIDUAL DISEASE TESTING PLATFORM
Source text for Eikon: ID:nGNX6S0tpd
Further company coverage: MYGN.O
(reuters.briefs@thomsonreuters.com)
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple